Bay Street News, 2024

WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing […]

PETACH TIKVA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming […]

Designation is based on preliminary safety and efficacy data from an ongoing Phase 1/2 trial in patients with platinum-resistant ovarian […]

WAUKESHA, Wis., Jan. 31, 2024 (GLOBE NEWSWIRE) — Generac Holdings Inc. (“Generac”) (NYSE: GNRC), a leading global designer and manufacturer […]

Justin, Texas, Jan. 31, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (NASDAQ: GOEV), a leading high-tech advanced mobility company, announced it […]

RICHMOND, Va., Jan. 31, 2024 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO), a Fortune 500 company and one of the […]

VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse […]

PITTSBURGH, Jan. 31, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in engineered materials, has been selected […]

VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; […]

– Company Selected to Receive $200,000 Ontario Government Grant – VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Solstice […]